CompanyCore
UK company intelligence
Company profile report
Prepared 28 July 2026
C3 BIOTECHNOLOGIES (HYPERSONICS) LIMITED
15401074 · ltd · incorporated 2024-01-09
1. Company facts
- Status
- active
- Lifecycle
- 🌿 Early-stage — Trading and building — modest revenue, not yet scaled.
- Jurisdiction
- england-wales
- Registered office
- 20 Mannin Way, Lancaster, LA1 3SW, England
- SIC codes
- 72110 — Research and experimental development on biotechnology; 74909 — Other professional, scientific and technical activities n.e.c.
- Accounts next due
- 2027-06-30
- Confirmation statement next due
- 2027-01-22
2. Directors (1 active)
- SCRUTTON, Nigel, Professor
- director · appointed 2024-01-09 · born 4/1964 (age 62)
3. Shareholders (1 active)
- C3 Biotechnologies Limited
- 75-100% shares · 75-100% voting · board control
4. Group structure
C3 Biotechnologies Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
- C3 Biotechnologies Limited
- Corporate parent · 75-100%
Headline verdict
- Opportunity score
- 72/100 (Strong)
- Owner dependency
- critical — 88/100
- Red flags
- 0 high · 1 medium · 0 low